Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

13 results
Display

Cellular Effects of Troglitazone on YD15 Tongue Carcinoma Cells

Ta Thi L, Yoo H

An FDA approved drug for the treatment of type II diabetes, Troglitazone (TRO), a peroxisome proliferator–activated receptor gamma agonist, is withdrawn due to severe idiosyncratic hepatotoxicity. In the search for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Inhibitory Effect of Testosterone on PPARγ-induced Adipogenesis

Jeong S

BACKGROUND: Peroxisome proliferator-activated receptor γ (PPARγ) plays a major role in adipocyte differentiation. Testosterone is well known for inhibiting adipocyte metabolism in men. To investigate the inhibitory mechanism of testosterone...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Troglitazone Enhances the Apoptotic Response of DLD-1 Colon Cancer Cells to Photodynamic Therapy

Park H, Ko SH, Lee JM, Park JH, Choi YH

PURPOSE: The aim of this study was to investigate whether the peroxisomal proliferator-activated receptor gamma (PPARγ) ligand troglitazone in combination with photodynamic therapy (PDT) enhances the apoptotic response of DLD-1...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of troglitazone on radiation sensitivity in cervix cancer cells

An Z, Liu X, Song H, Choi C, Kim WD, Yu JR, Park WY

PURPOSE: Troglitazone (TRO) is a peroxisome proliferator-activated receptor gamma (PPARgamma) agonist. TRO has antiproliferative activity on many kinds of cancer cells via G1 arrest. TRO also increases Cu2+/Zn2+-superoxide dismutase (CuZnSOD)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Over-expression of PTEN Involved in Troglitazone-induced Apoptosis in Human Osteosarcoma Cells

Yoon SJ, Zhou L, Kim JR

PURPOSE: We investigated the effects of phosphatase and tensin homologue deleted on chromosome 10 gene phosphatase and tensin homologue deleted on chromosome 10 gene (PTEN) expression on the cell proliferation...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Troglitazone on Thermal Sensitivity in Uterine Cervix Cancer Cells

Lee JH, Kim WD, Yu JR, Park WY

PURPOSE: Troglitazone (TRO), a PPAR-gamma agonist, can reduce heat shock protein (HSP) 70 and increase the antioxidant enzymes, such as superoxide dismutase (SOD) and catalase, which might affect thermal sensitivity....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Co-treatment with Dexamethasone and Troglitazone on Transcription and Secretion of IL-8 in the A549 Airway Epithelial Cells

  • KMID: 2234553
  • Korean J Asthma Allergy Clin Immunol.
  • 2008 Dec;28(4):292-297.
BACKGROUND: Glucocorticoid is a widely used anti-inflammatory agent in a variety of diseases. Recently, peroxisome proliferator activated receptor gamma (PPAR gamma) ligand has been shown to exert a potential anti-inflammatory...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Synergistic Apoptotic Effect of Combination Treatment with Troglitazone and COX-2 Inhibitor in Glioma Cells

Kim KR, Park MY, Park HS, Jang KY, Moon WS, Lee DG, Kang MJ

  • KMID: 1521688
  • Korean J Pathol.
  • 2007 Feb;41(1):1-6.
BACKGROUND: The use of troglitazone (a PPARgamma ligand) and COX-2 inhibitor have been intensively studied for inhibition of tumor growth in cancer treatment, but the anti-tumor effect with a combination...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antiproliferative Effect of Phenylbutyrate in AsPC-1 Pancreatic Cancer Cell Line

Jin C, Park JW, Choi JW, Kang H, Jin GB, Choi SM, Park SS, Ryu D, Jang LC

  • KMID: 2244242
  • Korean J Hepatobiliary Pancreat Surg.
  • 2006 Mar;10(1):1-9.
PURPOSE: Phenylbutyrate is an effective redifferentiating agent in several human cancers. Recently phenylbutyrate has been reported to inhibit histone deacetylase activity. We investigated the effects of sodium 4-henylbutyrate (Na-4-PB) on...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of the Peroxisome Proliferator-Activated Receptor Ligand Troglitazone in Osteosarcoma Cell Lines

Kim YJ, Kim TK, Park JY, Kim HJ, Lee JW

  • KMID: 2106194
  • J Korean Orthop Assoc.
  • 2005 Sep;40(5):591-597.
PURPOSE: We wanted to investigate the effects of Troglitazone (TRO) on the cellular growth in two human osteosarcoma cell lines (U2OS and HOS). MATERIALS AND METHODS: Cell viability was assessed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Peroxisome Proliferator-Activated Receptor gammaActivation Promotes Adipogenesis in Human Mesenchymal Stem Cells

Kim EJ, Kim SH, Kim YH, Kim SJ, Hahn SB, Lee JW

  • KMID: 2023943
  • J Korean Orthop Res Soc.
  • 2003 Apr;6(1):127-134.
PURPOSE: In this study, we determined that the troglitazones could induce uniform adipogenesis of human mesenchymal stem cells (MSCs) within a short time in a dose- and a time-dependent manners....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Troglitazone on Glucose Transport in Human Skeletal Muscle Cell Cultures from Obese Non-diabetic and Obese Non-insulin Dependent Diabetes Mellitus

Ciaraldi T, Henry RR, Park KS, Lee HK

  • KMID: 2178010
  • J Korean Diabetes Assoc.
  • 1998 Jun;22(2):164-172.
BACKGROUND: Skeletal muscle is the principal tissue of insulin resistance in obese non-diabetic and non-insulin dependent diabetic(NIDDM) subjects. Troglitazone(Tgz), a member of thiazolidinedione class of compounds, has been shown to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Troglitazone on Glycogen synthase Activity in Human skeletal Muscle Culture from Obese Non-Diabetic and Obese Non-insulin Dependent Diabetes Mellitus

Carter LA, Ciaraldi T, Henry RR, Park KS, Lee HK

  • KMID: 2137370
  • J Korean Diabetes Assoc.
  • 1997 Sep;21(3):254-261.
BACKGROUND: Skeletal muscle is the principal tissue of insulin resistance in obese and non-insulin dependent diabetic(NIDDM) subjects. Troglitazone, a member of thiazolidinedione class of compounds, has been shown to improve...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr